Given the pandemic and need for clarity, NPF developed a COVID-19 Task Force. Listen as Co-Chairs, dermatologist Dr. Joel Gelfand, Director, Psoriasis and Phototherapy Treatment Center at Penn, and rheumatologist Dr. Christopher Ritchlin, Co-Director, Psoriasis Center, University of Rochester Medical Center in New York, discuss the evidence and content of NPF's 22 guidance statements addressing effects, risks, and best practices for treatment of patients with psoriatic disease. For disclosures and to claim credit, go to https://www.eeds.com/em/1545.